February 20, 2025

NY Sues Major Vape Distributors Over Youth Marketing

Attorney General Letitia James files lawsuit against 13 e-cigarette companies for allegedly targeting minors with flavored nicotine products, seeking hundreds of millions in damages and penalties.

Conexiant

February 18, 2025

FDA Qualifies Two-Level RDL for AUD Trials

The drug development tool offers an alternative, clinically meaningful endpoint in clinical trials that evaluate pharmacologic treatments for alcohol use disorder.

Conexiant

February 12, 2025

Psychiatrist Settles False Claims, Controlled Substances Allegations

A Connecticut psychiatrist agreed to a $455K settlement after an investigation identified fraudulent Medicare claims and unsafe controlled substance prescribing practices, resulting in DEA sanctions and a 20-year exclusion from federal health programs.

Conexiant

February 12, 2025

Phase III Trial Targets Venous Leg Ulcers

With no new FDA-approved drugs for chronic wound debridement since 1965, MediWound's phase 3 trial tests EscharEx for venous leg ulcers in 216 patients.

Reuters

February 04, 2025

FDA Approves Clinical Trials for Genetically Modified Pig Kidney Transplants

FDA-cleared clinical trials will assess the safety, immunogenicity, and viability of genetically modified pig kidney transplants in patients with end-stage renal disease.

Conexiant

January 31, 2025

FDA Approves Suzetrigine as First-in-Class Non-Opioid Pain Treatment

FDA approves suzetrigine for acute pain relief—the first new non-opioid analgesic in over 20 years.

Conexiant

January 28, 2025

Trial Data Behind FDA Psychiatric Approvals

Key trial data and insights behind US Food and Drug Administration approvals of novel psychiatric drugs are shown, highlighting methods, demographics, and pivotal outcomes.

Conexiant

January 27, 2025

FDA Approves New Leqembi Dosing Regimen

Leqembi gains FDA approval for updated intravenous dosing schedule for early Alzheimer’s disease.

Conexiant

April 29, 2024

Record Heat Waves Propel Surge in Heat-Related Illness

2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.

Conexiant